Study protocol: a mixed methods feasibility study for a loaded self-managed exercise programme for patellofemoral pain by Smith, Benjamin E. et al.
STUDY PROTOCOL Open Access
Study protocol: a mixed methods feasibility
study for a loaded self-managed exercise
programme for patellofemoral pain
Benjamin E. Smith1,2*, Paul Hendrick3, Marcus Bateman1, Fiona Moffatt3, Michael Skovdal Rathleff4,5, James Selfe6,
Toby O. Smith7 and Pip Logan2
Abstract
Background: Patellofemoral pain (PFP) is one of the most common forms of knee pain in adults under the age of
40, with a prevalence of 23% in the general population. The long-term prognosis is poor, with only one third of
people pain-free 1 year after diagnosis.
The biomedical model of pain in relation to persistent PFP has recently been called into question. It has been
suggested that interventions for chronic musculoskeletal conditions should consider alternative mechanisms of
action, beyond muscles and joints. Modern treatment therapies should consider desensitising strategies, with
exercises that target movements and activities patients find fearful and painful.
High-quality research on exercise prescription in relation to pain mechanisms, not directed at specific tissue
pathology, and dose response clearly warrants further investigation.
Our primary aim is to establish the feasibility and acceptability of conducting a definitive RCT which will evaluate
the clinical and cost-effectiveness of a loaded self-managed exercise programme for people with patellofemoral
pain.
Method: This is a single-centred, multiphase, sequential, mixed-methods trial that will evaluate the feasibility of
running a definitive large-scale randomised controlled trial of a loaded self-managed exercise programme versus
usual physiotherapy. Initially, 8–10 participants with a minimum 3-month history of PFP will be recruited from an
NHS physiotherapy waiting list and interviewed. Participants will be invited to discuss perceived barriers and
facilitators to exercise engagement, and the meaning and impact of PFP. Then, 60 participants will be recruited in
the same manner for the main phase of the feasibility trial. A web-based service will randomise patients to a loaded
self-managed exercise programme or usual physiotherapy. The loaded self-managed exercise programme is aimed
at addressing lower limb knee and hip weakness and is positioned within a framework of reducing fear/avoidance
with an emphasis on self-management. Baseline assessment will include demographic data, average pain within
the last week (VAS), fear avoidance behaviours, catastrophising, self-efficacy, sport and leisure activity participation,
and general quality of life. Follow-up will be 3 and 6 months. The analysis will focus on descriptive statistics and
confidence intervals. The qualitative components will follow a thematic analysis approach.
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Discussion: This study will evaluate the feasibility of running a definitive large-scale trial on patients with
patellofemoral pain, within the NHS in the UK. We will identify strengths and weaknesses of the proposed protocol
and the utility and characteristics of the outcome measures. The results from this study will inform the design of a
multicentre trial.
Trial registration: ISRCTN35272486.
Keywords: Mixed-methods study, Feasibility, Patellofemoral pain, Anterior knee pain, Exercise therapy
Background
Patellofemoral pain (PFP) is one of the most common
forms of knee pain in adults under the age of 40 [1–3],
with an estimated prevalence of 23% in the general
population [1]. Typically, symptoms include retropatella
pain, or diffuse peripatellar pain, aggravated by activities
that load the joint, such as climbing and descending
stairs, squatting and running [4].
The overall long-term prognosis for the majority of
patients with PFP is poor [5]. One third of patients are
pain-free 1 year after the diagnosis [5]. Patients will typ-
ically withdraw from participation in sport and leisure
activities [6, 7], and symptoms can continue for many
years [5, 8]. Furthermore, many individuals with PFP de-
velop associated psychological distress, such as fear
avoidance and catastrophising thoughts in relation to
their knee pain [9–11]. It is such a common, yet poorly
understood condition, that the Chartered Society of
Physiotherapy, UK (CSP), has ranked PFP the 3rd most
important topic out of 185 in their Musculoskeletal Re-
search Priority Project in 2012 [12].
There remains scientific debate and uncertainty
around the underlying aetiology of the condition [13],
and it is thought most likely to be multifactorial in its
origin [14]. There is currently little high-quality level 1
evidence on which to base conservative management
[15]. Historically, models of clinical reasoning based on
the patho-anatomical basis of tissue pathology and dif-
ferential diagnosis have labelled one major cause of PFP
as patellar mal-tracking/malalignment [14, 16–18], with
the supposition that various tissue structures could be
contributing, such as general muscle weakness [19], soft
tissue tightness [20], lower limb structural abnormalities
[21], movement dysfunction [22] and quadriceps mal-
timing [23]. It is thought that these deviations from the
‘normal’ affect patellar alignment, kinematics or joint
loading, resulting in greater stress between the patella
and femur and the development of pain and dysfunction
[14, 16–18]. This biomedical model of pain establishes a
direct relationship between tissue structure and pain
[24], and traditionally, the focus of physiotherapy treat-
ment has been aimed at reducing pain and improving
function by addressing these biomedical tissue struc-
tures; treatments including taping, stretches, exercises,
electrotherapy, joint mobilisations and foot orthoses
have all been suggested [16, 17]. However, systematic re-
views consistently acknowledge the limitations of in-
cluded studies when drawing their conclusions on the
effectiveness of these interventions [14, 15, 17, 25–27].
Even in relation to exercise therapy, which has the stron-
gest evidence-base [15], there remains insufficient evi-
dence on which to determine the best form and dose of
exercise [25].
Exercise therapy designed to load and temporarily ag-
gravate patients’ symptoms has been shown to be benefi-
cial for tendon pain [28], shoulder pain [29–31], low
back pain [32, 33] and plantar heel pain [34]. In agree-
ment with Nijs et al. [35], Littlewood et al. [36] hypothe-
sised that the positive response to the painful loaded
exercise programme could be attributed to the thera-
peutic impact upon the central nervous system. Specific-
ally, the exercise prescribed is aimed at addressing fear
avoidance and catastrophising beliefs within a frame-
work of ‘hurt not equalling harm’, with pain rationalised
as ‘de-conditioned’ tissue, thus in time, reducing the
overall sensitivity of the central nervous system, with a
modified pain output.
Exercise interventions for PFP have shown a ‘dose re-
sponse’; characteristically, the more exercise the patient
does the better their pain and functional improvement
in the long term. A study in Norway (n = 42) looked at a
high-dose regime versus a low-dose regime and con-
cluded that there was significant benefit in the high-dose
group over low dose in terms of pain and function at
12 weeks [37]. Strikingly, the 1-year follow-up showed
that the high-dose group had continued to improve in
terms of pain and function, while the low-dose group
had deteriorated [37, 38]. This finding is supported by a
more recent study looking at supervised exercises and
education versus education alone [39]. In this study, 121
adolescents were randomised into the two groups, with
exercise adherence monitored through attendance and
weekly text messages. They demonstrated that successful
outcome (defined as ‘completely recovered or strongly
improved’ on a seven-point Likert scale) was directly
correlated to the amount of exercise a patient did; if they
completed the exercises 0–1× a week, 21% recovered
compared with 55% who completed the exercises three
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or more times a week. A recent systematic review and
meta-analysis of painful exercises versus pain-free exer-
cises for chronic MSK pain found that protocols using
painful exercises offered a small, but significant benefit
over pain-free exercises in the short term and that pro-
tocols using painful exercises typically have higher loads
and dose of exercise [40]. The optimal dose of exercise
for the greatest improvements in PFP is still unknown
[25] and warrants further investigation in relation to
load and resistance.
High-quality research on exercise prescription in rela-
tion to pain mechanisms and dose response (or response
to load/resistance) clearly warrants further investigation,
particularly when considering the current paucity of
high-quality evidence on which to determine the best
form of exercise intervention for PFP.
Purpose
The primary aim is to establish the feasibility and ac-
ceptability of conducting a definitive RCT which will
evaluate the clinical and cost-effectiveness of a loaded
self-managed exercise programme for people with patel-
lofemoral pain compared to usual physiotherapy.
Secondary aims include establishing: if the devised
loaded self-managed exercise programme can be deliv-
ered as planned in an NHS physiotherapy outpatient
clinic; if the outcome measures are feasible to use within
an NHS setting; if reliable data can be collected; a sam-
ple size calculation for an RCT; if the intervention is ac-
ceptable and tolerable to participants and
physiotherapists; if it is feasible to recruit and randomise
participants; the potential barriers to recruitment and
the training package delivered to physiotherapists.
Methods
Study design
This is a single-centred, multiphase, sequential,
mixed-methods trial. It incorporates an initial qualita-
tive component, followed by a feasibility randomised
controlled trial (RCT), with a final qualitative compo-
nent. Reporting of this protocol will follow the
SPIRIT statement [41].
Phase 1 will recruit eight to ten participants, and indi-
vidual interviews will be performed with the purpose of
understanding the impact of PFP with their lives. Their
physiotherapy will continue as normal.
Phase 2: A clinical trial will then be conducted with 60
further participants (recruited separately to phase 1).
These participants will be randomised to the interven-
tion group or to the control group.
Phase 3: A sub group of participants (eight to ten)
from phase 2, along with a sub-group of the physiother-
apists involved in phase 2 (8–10), will be asked to take
part in individual interviews that will explore the
acceptability and feasibility of study design parameters
and the intervention from phase 2.
Recruitment
Selection of trial participants for phase 1 and phase 2
will follow the same procedure. Potential trial partici-
pants will be identified and triaged from the NHS
physiotherapy waiting list at Derby Teaching Hospitals
NHS Foundation Trust by the usual department physio-
therapists who perform referral triage. Patients are re-
ferred from general practitioners and from orthopaedics
and rheumatology hospital departments. An introduc-
tory letter accompanied by an information sheet and
consent form will be sent out to potential trial partici-
pants by a member of the clinical team. This will be
followed up by a telephone call from a member of the
clinical team offering further information and enquiring
about participation. Patients showing an initial interest
will be asked questions to check if they match the inclu-
sion criteria, and interview/assessments will be booked
with the research team.
Eligibility criteria
Based on a consensus gained from previous system-
atic reviews and studies [14, 39], the participants will
be recruited from the waiting list according to the
following criteria: men and women aged 18 to 40
who are able to give written informed consent; a clin-
ical diagnosis of unilateral or bilateral PFP of greater
than 3-month duration (if bilateral the worst knee
will be investigated); and anterior or retropatellar pain
reported on at least two of the following activities:
prolonged sitting, ascending or descending stairs,
squatting, jumping and running.
Exclusion criteria include previous knee surgery; await-
ing lower limb surgery; knee ligamentous instability; his-
tory of patellar dislocation; true knee locking or giving
way; reasons to suspect systemic pathology, or acute ill-
ness; pregnancy or breast feeding; patellar or iliotibial
tract tendinopathy; and not able to speak or understand
English.
Interventions
Phase 1—interviews
Interviews will explore perceived barriers and facilitators
to exercise engagement, the meaning to the participant
and impact of having PFP. This may be used to tailor
the intervention in phase 2 and to inform the phase 3
interviews, if appropriate.
A convenience sample of the first 10 participants re-
cruited will be invited to discuss factors surrounding the
meaning and lived experience of PFP. The interviews
will occur in the participant’s home or another suitable
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venue of their choice. There will be an interview sched-
ule to guide (but not lead) discussion.
Phase 2—pilot clinical trial
Exercise intervention The ‘experimental’ intervention
is a loaded self-managed exercise programme for the
knee and hip, aimed at addressing lower limb knee and
hip weakness [25]. It is set within a framework of redu-
cing fear/avoidance and with an emphasis on self-
management and reducing the need for direct physio-
therapy intervention.
Before any prescription of exercise, the physiotherapist
will spend a period of time educating the participant
about pain mechanisms. Descriptions of tissue-based
pathology models of pain, e.g. patellar mal-tracking, or
limb mal-alignment, will be actively discouraged and
challenged by the physiotherapist. The participant will
gain an evidence-based understanding of dysfunctional
central nociceptive processing as an explanation of
chronic and persistent pain [42] and the role and impact
of fear [43]. This period of intense learning is designed
to facilitate the reconceptualisation of pain, with an em-
phasis on descriptions of pain neuroscience rather than
psychology [44], and from the perspective and context
of the participant and their pain [45]. The education re-
garding pain mechanisms will take up a large portion of
clinical time, such as to address any beliefs or fear within
the participant that pain is a sign of tissue damage, and
will be delivered in a Socratic teaching style [46]. It is ex-
pected that the education period will be completed in
the first session, which typically lasts 30–40 min within
the NHS, but participants that require further re-
assurance may continue into their second session.
The exercise will be prescribed by the physiotherapist
and will typically involve body weight resistance in the
form of a modification of the ‘Step Down’ function test
[47], a single-leg squatting exercise sideways on a step.
By performing sideways, the participant will be able to
use the guide of the wall and/or banister more easily, as
guided by our patient and public involvement feedback.
The exercise requires balance, knee extension strength,
eccentric control and isometric hip strength. The partici-
pant will be advised to exercise to the point of fatigue,
such that it reproduces their pain and discomfort, but
ensuring the pain is manageable [48–50].
Exercise progression is guided by symptomatic re-
sponse, such that the participant is advised that on ces-
sation of the exercise, the pain should remain no worse
than pre-exercise [48]. Participants with more severe
pain will start on a lighter regime, and this will be
guided by the baseline functional assessment by the
treating physiotherapist. Participants will be advised to
exercise at a level they find acceptable and tolerable.
Participants are able to start exercising, if they wish, at a
very low level, with little or no short-term pain increase,
and progress when they feel comfortable and confident.
Regression will be in the form of reduced repetitions, or
lightening the exercise, for example to double leg squats
0–30° knee flexion. Progression can be in the form of in-
creased repetitions or increasing the load by moving to
plyometric exercises, such as jumping and hopping, for
participants with higher sporting requirements. The
physiotherapist will plan the exercise, motivate and re-
view participant’s physical performance and expectations
[35].
A single exercise approach will be used for this inter-
vention. Poor levels of exercise adherence are well docu-
mented [51], and it has been suggested that a single
exercise represents a pragmatic time saving approach
[52]. Additionally, as previously discussed, the optimal
dosage of an exercise prescription is unknown, and a
single exercise approach may allow better monitoring of
dosage and adherence. Importantly, it will enable the
participant to observe others (the physiotherapist) per-
form the task successfully, and facilitate the development
of mastery of the task. This combined with specific ver-
bal and social persuasion from the physiotherapist, will
further promote reconceptualisation of the pain, specific
to the participant and their context; all thought to be
key modifiers of perceived self-efficacy [53].
The participants will be advised that the exercise
should be performed twice a day. The participant will be
encouraged to self-direct in progressing/regressing the
repetitions, as guided by their pain response, thus fur-
ther internalising the locus of control and moving to-
wards self-management [53].
Goal setting will be a central part of the intervention.
The reconceptualisation of pain through the exercise
intervention leads to the reconceptualization of pain in
the participant’s daily activities, including sport and leis-
ure activity, and setting goals helps this transition.
Other self-management strategies employed will be
the discussion about managing ‘flare ups’ and potential
or perceived barriers to successful outcomes [35, 52].
This will be through a thorough questioning and discus-
sion with the physiotherapist and participant, questions
such as the following: Is this safe for your knee? Is exer-
cise good for you? Are you confident of completing this
exercise? What do you think will happen? Why do you
think that? It is thought that a discussion based on this
approach will reveal the participant’s perception of exer-
cise, and potential barriers and fears [35].
Keeping the treatment pragmatic, timing over follow-
ups, the number of treatment sessions, frequency and
discharge and physiotherapy concomitant treatments
will be at the discretion of the qualified physiotherapist,
but with the aim of the programme being self-
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management, self-directed exercise and discouraging
concomitant treatments. The mean number of sessions
for physiotherapy treatment of PFP is eight [54], and the
prediction is that self-management strategies should
lower the expected number of treatment sessions for the
intervention group to three to five sessions. The timings
of the follow-up appointments are also pragmatic in na-
ture and at the discretion of the physiotherapist in dis-
cussion with the participant. Following the problem
solving and barrier discussion, the physiotherapist will
have understanding of the participant’s ongoing per-
ception of their pain. Those that require further re-
assurance may return sooner, 1 to 3 weeks, and those
that are comfortable to self-manage sooner will return
after a longer period of time, 4 to 6 weeks, or not at
all in some cases. All participants have the opportun-
ity to telephone for support if required.
To avoid cross-contamination between the two
groups, the delivered intervention group will be treated
by different qualified physiotherapists, who will be ex-
cluded from treating participants from the comparator
group. Furthermore, physiotherapists treating ‘usual
physiotherapy’ will not receive the intervention training
package. The intervention training package will be deliv-
ered to the treating physiotherapists by the research
team. The training package will consist of 2 × 2 h ses-
sions, scheduled to fit into the usual in-service training
slots.
The comparator Usual physiotherapy typically involves
strengthening exercises [55–57], taping [17, 58],
stretches [59] and foot orthoses [60], and these are often
aimed at restoring the assumed patella malalignment
[16, 17]. The comparator will be usual physiotherapy as
directed by the normal assessment and clinical decision-
making by the treating physiotherapist. Details about the
nature of the treatments will be collected.
Phase 3—interviews
Potential interviewees will be purposively sampled from
the phase 2 RCT with initial contact made via telephone
to ask whether they would be willing to participate (in-
formation sheet and consent form for phases 2 and 3 are
combined). A sample of eight to ten participants will be
required with a sample of responders and non-
responders, from both intervention arm and comparator
group, with 1:2 proportion of males to females to reflect
gendered differences in prevalence [1]. Participants lost
to follow-up will be telephoned and encouraged to take
part. This process will begin 6 months after randomisa-
tion. If the participant agrees, a convenient time will be
arranged to complete an interview at the participant’s
home or physiotherapy clinic. Consent for the phase 2
clinical trial will include consent for participation in
phase 3.
Treating physiotherapists will be invited to take part in
interviews. A purposive sample of eight to ten will be re-
quired, with a mixture representing both the interven-
tion group and comparator group, with different grades
and length of clinical experience. Consent for this will
be taken separately.
The emphasis within the intervention arm is towards
self-management and exercises that are performed with
pain. Therefore, the aim of the qualitative investigation
is to give an insight into the participants’ and physiother-
apists’ perceptions and experiences of the process. There
have been recent developments on our understanding of
the impact of patients’ and therapists’ attitudes and be-
liefs on pain [61]; therefore, these factors are extremely
important to understand. Also, study design parameters
will be discussed to explore recruitment and randomisa-
tion in this participant group. All interviews will be face-
to-face at a location and time convenient to the inter-
viewee. Interviews will be semi-structured and will
broadly consider the acceptability and practicality of the
exercise programme. For participants, data collection
will consider views on the nature and form of the exer-
cise; perception of its benefits, difficulties and barriers;
and perceptions of study design, i.e. recruitment, con-
sent, data collection and follow-up periods. For physio-
therapists, data collection will consider views on the
nature and form of the exercise; perception of its bene-
fits, difficulties and barriers; and views on the delivery of
the training package. The interviews will be guided by a
semi-structured schedule.
Outcome assessments
Our patient and public involvement representative has
reviewed and approved the outcome assessments, and
has a total estimated completion time of 10–15 min.
The schedule for assessments is found in the SPIRIT fig-
ure (Table 1).
Baseline demographic data will include age, sex and
duration of symptoms. The primary outcome measure
that we will test the feasibility of will be a global rating
of change at follow-up, the proportion of participants
who have recovered (defined as ‘completely recovered’
or ‘strongly recovered’), measured on a 7-point Likert
scale ranging from ‘completely recovered’ to ‘worse than
ever’ [39, 57, 62].
Secondary outcome measures that we will test the
feasibility of using will include: visual analogue scale
(VAS) for pain, kinesiophobia, catastrophizing, self-
efficacy, sport participation and the generic health out-
come Euro-QOL (EQ-5D-5L).
Average pain within the last week will be measured on
the visual analogue scale (VAS) 0 to 10 cm [63]; 0
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represents no pain, 10 the worst pain possible; this scale
has been shown to be valid for PFP with a minimal clin-
ically important difference (MCID) of 2 [64].
Fear associated with avoidance behaviours and kinesio-
phobia will be measured with the Tampa Scale for Kine-
siophobia (TSK) [9, 65]. This is a 17-item questionnaire
widely used for the assessment of fear of movement and
has been shown to be reliable and valid for an English
speaking population with spinal pain. Each question is
scored on a 4-point Likert scale ranging from ‘strongly
disagree’ (1) to strongly agree (4), giving a total possible
score of 17 to 68.
Catastrophizing will be measured by means of the
‘Pain Catastrophizing Scale’ (PCS) [66]. The PCS scale
is a 13-item questionnaire used to explore partici-
pants’ thoughts and feelings when experiencing pain.
Each question asks the degree with which the partici-
pant agrees with the statement and is scored on a 5-
point Likert scale ranging from ‘not at all’ (0) to ‘all
the time’ (4), giving a total possible score of 0 to 52.
Self-efficacy has been shown to be a strong predictor of
disability in patients with MSK pain [67]; therefore, the
General Self Efficacy Scale will also be used (GSES) [68].
The GSES is a 10-item questionnaire with each question
asking the degree with which the participant agrees with
the statement, with a 4-point Likert scoring structure ran-
ging from ‘not at all’ (1) to ‘exactly true’ (4). The questions
are used to explore the participants’ perceived belief at
coping with a range of stressful and challenging demands,
with a total possible score of 10 to 40. The GSES has been
shown to have high reliability and validity across multiple
languages and settings [69].
Table 1 SPIRIT figure. Schedule of enrolment, interventions and assessments
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Patients characteristically withdraw from participa-
tion in sport and leisure activities [6]; therefore, the
number of times the participant has participated in
leisure time sport or exercises within a week will be
recorded.
The generic EQ-5D-5L is a generic health outcome
used widely internationally [70]. The questionnaire has
five questions about mobility, usual activities, self-care,
pain and discomfort and anxiety and depression. The re-
sults are converted into in single summary index and
can be used to aid and assist any future economic evalu-
ation planned for the definitive RCT.
Compliance is the act of conforming and following the
prescribed dosage, timing and frequency of the exercise.
Feasibility outcomes of compliance levels will be moni-
tored through a participant activity diary. Participants
will be asked to complete an exercise diary daily for 6
months indicating how many repetitions they completed
of their exercise.
Non-responders will be telephoned after 7 days to en-
courage them to complete the forms and return them.
Sample size
A formal sample size calculation will not be performed
since this is a feasibility study. We therefore envisage be-
ing able to recruit 30 participants into each treatment
arm, and we consider that this will give a robust and
useful amount of information [71]. Part of the feasibility
study is to investigate the feasibility of recruitment.
However, we envisage recruiting 60 participants in
13 months.
We will use the primary outcome measure, the global
rating of change scale, to inform a sample size calcula-
tion for a definitive RCT.
Randomisation
Patients who fulfil the inclusion and exclusion criteria, read
and understood the patient information sheet and have
given written consent to take part in the trial will be rando-
mised to either the intervention or the control. A web-
based randomisation service with secure password pro-
tected login using random variable block-size will be used.
Due to the nature of therapeutic studies, blinding of
the participants and physiotherapists is not possible [72].
Data collection methods
Phases 1 and 3
Interviews will be recorded with a digital recorder. The
interviews will then be transcribed verbatim and
analysed.
Phase 2
Baseline data will be captured prior to randomisation in
the physiotherapy clinic. Follow-up assessments will be
3 and 6 months (by post with a stamped addressed enve-
lope for return). Participants will be asked to post back
their exercises diary at the 6-month follow-up.
Planned data analysis
Phases 1 and 3
The qualitative components will follow a thematic ana-
lysis approach, as described by Braun and Clarke (2006)
[73]. Line by line coding, leading to a thematic analysis
(using an abductive research strategy), will be used. Fol-
lowing data familiarisation, initial codes will be gener-
ated and peer reviewed, by a member of the research
group, to search for common themes. This will be car-
ried out using the NVivo software (NVivo qualitative
data analysis Software; QSR International Pty Ltd., Ver-
sion 11, 2015). For phase 1, the analysis will assess the
lived experience of PFP; for phase 3, the analysis will
broadly assess acceptability and feasibility of study de-
sign, intervention and training package to
physiotherapists.
Phase 2
The analysis will focus on descriptive statistics and con-
fidence intervals for the variables we are obtaining. The
characteristics of the participants will also be described
using means, standard deviations and ranges for quanti-
tative variables and counts and proportions for categor-
ical variables.
As this is a feasibility study, we are testing our ability
to collect data; therefore, no data imputation will be per-
formed to account for any missing data.
Feasibility threshold will be set at 75% for recruitment.
Feasibility threshold will be set at 75% to assess reliabil-
ity and completeness of outcome measures. Data relating
to timing of the return of outcome forms, department
referral rate, recruitment rate and numbers lost to
follow-up will be recorded. Acceptability and tolerability
of the treatment intervention will be assessed through
completeness of outcome measures and feedback from
the phase 3 qualitative interviews.
Monitoring
The exercise intervention is low risk and is commonly
used in the population. The occurrence of an adverse
event as a result of participation within this study is not
expected, and no adverse event data will be collected.
Patient and public involvement
This research project has been driven by the views of
people suffering from patellofemoral pain (PFP). Patients
who receive physiotherapy for PFP have been consulted
for their views, including patient members of the Steer-
ing Group Committee. Thoughts and preferences to
current programmes of therapy and treatment have been
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requested, and these views have been incorporated into
the planning, design, application and dissemination of
this study.
Patients stressed the importance of ensuring minimal
number of exercises for improved adherence; the tailor-
ing of the physiotherapy intervention around their usual
sport/hobbies (where appropriate); and the capability of
telephone support when required at short notice.
The main exercise of the intervention itself was
adapted after consultation with patients. Initially, the
intervention was an exercise based upon the ‘Step Down’
function test [47]. The feedback from the patients was
that performing the same manoeuvre sideways, rather
than facing down the step, allowed them to use the
guide of the wall and/or banister with their hands. This
has been incorporated into the intervention.
Discussion
We have presented the rationale and design of a mixed-
methods feasibility study for a loaded self-managed exer-
cise programme for PFP. The premise that a loaded self-
managed lower limb strengthening exercise, that is not
directed at specific tissue pathology, but rather based on
the neurophysiology of pain, set within clearly defined
boundaries, will have a positive impact upon fear-
avoidance, catastrophizing and self-efficacy behaviour
and patient-reported pain levels. The feasibility of a large
definitive RCT will either be established or negated, and
the results of the trial will be published when they are
available.
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